What moves Germans
The British switch to campaign mode, cannabis is to be legalized or provisioning for the twilight years, but how - are some of the issues
Receive up-to-date information about the company directly via push notification
Many topics move Germany. Germany's politicians are discussing a controlled release of cannabis, perhaps through pharmacies or licensed businesses. The European cannabis market is growing and growing. Countries in Europe are rethinking the use of medicinal cannabis to give patients access to alternative treatment. Other countries allow recreational use, such as Canada.
Companies such as RavenQuest BioMed, which produce cannabis, serve the increasing demand. The company has successful manufacturing facilities in Markham, Ontario and Edmonton, Alberta. The collaboration with McGill University is a special feature of RavenQuest BioMed. https://www.youtube.com/watch?v=UgUsP8r2KiA&t=18s -
A seemingly never-ending topic is Brexit. Now, January 31 is to be the leaving date. New elections will be held in the UK on 12 December. Uncertainties have therefore not yet been removed and should therefore give the gold price further impetus. And the price of gold and its development is an important issue when it comes to old-age provision. Hardly a day goes by without reading and hearing about the bleak prospects for statutory pensions. Private provision is absolutely necessary, and this is also a constant occurrence. But how, when saving is no longer worth it.
The idea of investing part of your savings in gold and selected gold stocks in the longer term in order to preserve and, if possible, increase your assets is a good option and should be taken into consideration. There are many gold companies, so you have to choose carefully. For example, Auryn Resources is convincing. - https://www.youtube.com/watch?v=A_jrxUZN-BE=1s - Auryn Resources pursues seven projects and places particular emphasis on high-grade projects. Most important are the Committee Bay Gold Project in Nunavut and the Sombrero Copper Gold Project in Peru.
Current corporate information and news releases from RavenQuest BioMed (
www.resource-capital.ch/de/unternehmen/ravenquest-biomed-inc/)
and Auryn Resources (www.resource-capital.ch/de/unternehmen/auryn-resources-inc/).
In accordance with §34 WpHG I would like to point out that partners, authors and employees may hold shares in the respective companies and that there is therefore a potential conflict of interest. No guarantee for the translation into German. Only the English version of these messages is valid.
Disclaimer: The information provided does not constitute any form of recommendation or advice. The risks involved in securities trading are expressly pointed out. No liability can be accepted for damages arising from the use of this blog. I would like to point out that shares and in particular warrant investments are generally associated with risk. The total loss of the invested capital cannot be excluded. All information and sources are carefully researched. For the correctness of all contents however no guarantee is taken over. Despite the greatest care, I expressly reserve the right to make an error, particularly with regard to figures and prices. The information contained herein has been obtained from sources believed to be reliable, but does not claim to be accurate or complete. Due to judicial judgements the contents of linked external sides are to be answered for also (so among other things regional court Hamburg, in the judgement of 12.05.1998 - 312 O 85/98), as long as no express dissociation from these takes place. Despite careful content control, I do not assume any liability for the content of linked external sites. The respective operators are solely responsible for their content. The disclaimer of Swiss Resource Capital AG also applies: https://www.resource-capital.ch/de/disclaimer-agb/